Articoli di riviste sul tema "Preclinical oncology"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Preclinical oncology".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Kahn, Jenna, Philip J. Tofilon e Kevin Camphausen. "Preclinical models in radiation oncology". Radiation Oncology 7, n. 1 (2012): 223. http://dx.doi.org/10.1186/1748-717x-7-223.
Testo completoKumari, Rajendra. "Refining Preclinical Modeling in Oncology". Genetic Engineering & Biotechnology News 33, n. 19 (novembre 2013): 34–35. http://dx.doi.org/10.1089/gen.33.19.14.
Testo completoIbarrola-Villava, Maider, Andrés Cervantes e Alberto Bardelli. "Preclinical models for precision oncology". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1870, n. 2 (dicembre 2018): 239–46. http://dx.doi.org/10.1016/j.bbcan.2018.06.004.
Testo completoGardner, Eric E., e Charles M. Rudin. "Preclinical oncology — reporting transparency needed". Nature Reviews Clinical Oncology 13, n. 1 (15 dicembre 2015): 8–9. http://dx.doi.org/10.1038/nrclinonc.2015.216.
Testo completoClézardin, Philippe, Ismahène Benzaïd e Peter I. Croucher. "Bisphosphonates in preclinical bone oncology". Bone 49, n. 1 (luglio 2011): 66–70. http://dx.doi.org/10.1016/j.bone.2010.11.017.
Testo completoThöni, C. "Preclinical research in oncology: Gender aspects". memo - Magazine of European Medical Oncology 4, n. 4 (dicembre 2011): 217–20. http://dx.doi.org/10.1007/s12254-011-0295-y.
Testo completoBOULEFTOUR, WAFA, BENOITE MERY, ELISE ROWINSKI, CHARLENE RIVIER, ELISABETH DAGUENET e NICOLAS MAGNE. "Cardio-Oncology Preclinical Models: A Comprehensive Review". Anticancer Research 41, n. 11 (novembre 2021): 5355–64. http://dx.doi.org/10.21873/anticanres.15348.
Testo completoWittenburg, Luke A., e Daniel L. Gustafson. "Optimizing preclinical study design in oncology research". Chemico-Biological Interactions 190, n. 2-3 (aprile 2011): 73–78. http://dx.doi.org/10.1016/j.cbi.2011.01.029.
Testo completoZumberg, Marc S., Virginia C. Broudy, Elizabeth M. Bengtson e Scott D. Gitlin. "Preclinical Medical Student Hematology/Oncology Education Environment". Journal of Cancer Education 30, n. 4 (31 gennaio 2015): 711–18. http://dx.doi.org/10.1007/s13187-014-0778-8.
Testo completoHormuth, David A., Anna G. Sorace, John Virostko, Richard G. Abramson, Zaver M. Bhujwalla, Pedro Enriquez‐Navas, Robert Gillies et al. "Translating preclinical MRI methods to clinical oncology". Journal of Magnetic Resonance Imaging 50, n. 5 (29 marzo 2019): 1377–92. http://dx.doi.org/10.1002/jmri.26731.
Testo completoPatel, Tulsi Dipakbhai, Gunjan e Venkata Gangadhar Vanteddu. "Bio-markers of immuno-oncology". Journal of Pharmaceutical and Biological Sciences 11, n. 2 (15 febbraio 2024): 105–11. http://dx.doi.org/10.18231/j.jpbs.2023.017.
Testo completoHolmen Olofsson, Gitte, Agnete Witness Praest Jensen, Manja Idorn e Per thor Straten. "Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo". International Journal of Molecular Sciences 21, n. 11 (27 maggio 2020): 3816. http://dx.doi.org/10.3390/ijms21113816.
Testo completoWang, Yufei, Sarah E. Shelton, Gabriella Kastrunes, David A. Barbie, Gordon J. Freeman e Wayne A. Marasco. "Preclinical models for development of immune–oncology therapies". Immuno Oncology Insights 03, n. 08 (3 ottobre 2022): 396–98. http://dx.doi.org/10.18609/ioi.2022.41.
Testo completovan Bekkum, Dirk W. "Preclinical experiments". Best Practice & Research Clinical Haematology 17, n. 2 (giugno 2004): 201–22. http://dx.doi.org/10.1016/j.beha.2004.04.003.
Testo completoFiordelisi, Maria Felicia, Carlo Cavaliere, Luigi Auletta, Luca Basso e Marco Salvatore. "Magnetic Resonance Imaging for Translational Research in Oncology". Journal of Clinical Medicine 8, n. 11 (6 novembre 2019): 1883. http://dx.doi.org/10.3390/jcm8111883.
Testo completoSitta, Juliana, Pier Paolo Claudio e Candace M. Howard. "Virus-Based Immuno-Oncology Models". Biomedicines 10, n. 6 (18 giugno 2022): 1441. http://dx.doi.org/10.3390/biomedicines10061441.
Testo completoFranklin, Maryland Rosenfeld, Suso Platero, Kamal S. Saini, Giuseppe Curigliano e Steven Anderson. "Immuno-oncology trends: preclinical models, biomarkers, and clinical development". Journal for ImmunoTherapy of Cancer 10, n. 1 (gennaio 2022): e003231. http://dx.doi.org/10.1136/jitc-2021-003231.
Testo completoChen, Stephen R., Frederick F. Lang e Peter Kan. "Preclinical animal brain tumor models for interventional neuro-oncology". Journal of NeuroInterventional Surgery 14, n. 5 (12 aprile 2022): neurintsurg—2022–018968. http://dx.doi.org/10.1136/neurintsurg-2022-018968.
Testo completoTamm, Ingo, e Mandy Wagner. "Antisense Therapy in Clinical Oncology: Preclinical and Clinical Experiences". Molecular Biotechnology 33, n. 3 (2006): 221–38. http://dx.doi.org/10.1385/mb:33:3:221.
Testo completoOertel, Michael, Martina Schmitz, Jan Carl Becker, Hans Theodor Eich e Anna Schober. "Successful integration of radiation oncology in preclinical medical education". Strahlentherapie und Onkologie 195, n. 12 (15 luglio 2019): 1104–9. http://dx.doi.org/10.1007/s00066-019-01492-z.
Testo completoWulf-Goldenberg, A., M. Stecklum, Z. Reiner, I. Fichtner e J. Hoffmann. "Mouse models for translational preclinical research in immuno-oncology". European Journal of Cancer 69 (dicembre 2016): S53—S54. http://dx.doi.org/10.1016/s0959-8049(16)32746-0.
Testo completoBarachini, Serena, Mariangela Morelli, Orazio Santo Santonocito e Chiara Maria Mazzanti. "Preclinical glioma models in neuro-oncology: enhancing translational research". Current Opinion in Oncology 35, n. 6 (1 settembre 2023): 536–42. http://dx.doi.org/10.1097/cco.0000000000000997.
Testo completoGreen, Jonathan R. "Bisphosphonates: Preclinical Review". Oncologist 9, S4 (settembre 2004): 3–13. http://dx.doi.org/10.1634/theoncologist.9-90004-3.
Testo completoFletcher, Nicholas, Aditya Ardana e Kristofer J. Thurecht. "Preclinical Imaging of siRNA Delivery". Australian Journal of Chemistry 69, n. 10 (2016): 1073. http://dx.doi.org/10.1071/ch16079.
Testo completoVanhaezebrouck, Isabelle F., e Matthew L. Scarpelli. "Companion Animals as a Key to Success for Translating Radiation Therapy Research into the Clinic". Cancers 15, n. 13 (27 giugno 2023): 3377. http://dx.doi.org/10.3390/cancers15133377.
Testo completoFosse, Vibeke, Emanuela Oldoni, Chiara Gerardi, Rita Banzi, Maddalena Fratelli, Florence Bietrix, Anton Ussi, Antonio L. Andreu e Emmet McCormack. "Evaluating Translational Methods for Personalized Medicine—A Scoping Review". Journal of Personalized Medicine 12, n. 7 (19 luglio 2022): 1177. http://dx.doi.org/10.3390/jpm12071177.
Testo completoStewart, Elizabeth, e Burgess Freeman. "YIA20-006: Preclinical Pediatric MATCH". Journal of the National Comprehensive Cancer Network 18, n. 3.5 (20 marzo 2020): YIA20–006. http://dx.doi.org/10.6004/jnccn.2019.7485.
Testo completoPugh, Trevor J., e Benjamin Haibe-Kains. "REFLECTions on Combination Therapies Empowered by Data Sharing". Cancer Discovery 12, n. 6 (2 giugno 2022): 1416–18. http://dx.doi.org/10.1158/2159-8290.cd-22-0330.
Testo completovan Rijt, Antonia, Evan Stefanek e Karolina Valente. "Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches". Cancers 15, n. 18 (7 settembre 2023): 4466. http://dx.doi.org/10.3390/cancers15184466.
Testo completoValluru, Keerthi S., Katheryne E. Wilson e Jürgen K. Willmann. "Photoacoustic Imaging in Oncology: Translational Preclinical and Early Clinical Experience". Radiology 280, n. 2 (agosto 2016): 332–49. http://dx.doi.org/10.1148/radiol.16151414.
Testo completoHasmann, Max, Benno Rattel e Roland Löser. "Preclinical data for Droloxifene". Cancer Letters 84, n. 2 (settembre 1994): 101–16. http://dx.doi.org/10.1016/0304-3835(94)90364-6.
Testo completoDholakia, Jhalak, Carly Scalise e Rebecca C. Arend. "Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies". Cancers 13, n. 7 (2 aprile 2021): 1694. http://dx.doi.org/10.3390/cancers13071694.
Testo completoLiu, Jinsha, Priyanka Pandya e Sepideh Afshar. "Therapeutic Advances in Oncology". International Journal of Molecular Sciences 22, n. 4 (18 febbraio 2021): 2008. http://dx.doi.org/10.3390/ijms22042008.
Testo completoGreen, Jonathan R. "Preclinical pharmacology of zoledronic acid". Seminars in Oncology 29, n. 6 Suppl 21 (dicembre 2002): 3–11. http://dx.doi.org/10.1053/sonc.2002.37421.
Testo completoMUNDY, G. "Preclinical models of bone metastases". Seminars in Oncology 28 (agosto 2001): 2–8. http://dx.doi.org/10.1016/s0093-7754(01)90225-8.
Testo completoAKITA, R., e M. SLIWKOWSKI. "Preclinical studies with Erlotinib (Tarceva)". Seminars in Oncology 30, n. 3 (giugno 2003): 15–24. http://dx.doi.org/10.1016/s0093-7754(03)70011-6.
Testo completoKim, Minlee, Andrea L. Kasinski e Frank J. Slack. "MicroRNA therapeutics in preclinical cancer models". Lancet Oncology 12, n. 4 (aprile 2011): 319–21. http://dx.doi.org/10.1016/s1470-2045(11)70067-5.
Testo completoDuncan, R., L. W. Seymour, K. Ulbrich, F. Spreafico, M. Grandi, M. Ripamonti, M. Farao e A. Suarato. "Preclinical evaluation of polymer-bound doxorubicin". European Journal of Cancer and Clinical Oncology 27 (gennaio 1991): S52. http://dx.doi.org/10.1016/0277-5379(91)91369-t.
Testo completoPriester, Marjolein I., Sergio Curto, Gerard C. van Rhoon e Timo L. M. ten Hagen. "External Basic Hyperthermia Devices for Preclinical Studies in Small Animals". Cancers 13, n. 18 (15 settembre 2021): 4628. http://dx.doi.org/10.3390/cancers13184628.
Testo completoDasgupta, Pushan, Veerakumar Balasubramanyian, John F. de Groot e Nazanin K. Majd. "Preclinical Models of Low-Grade Gliomas". Cancers 15, n. 3 (18 gennaio 2023): 596. http://dx.doi.org/10.3390/cancers15030596.
Testo completoLau, Joseph, Etienne Rousseau, Daniel Kwon, Kuo-Shyan Lin, François Bénard e Xiaoyuan Chen. "Insight into the Development of PET Radiopharmaceuticals for Oncology". Cancers 12, n. 5 (21 maggio 2020): 1312. http://dx.doi.org/10.3390/cancers12051312.
Testo completoGargiulo, Sara, Sandra Albanese e Marcello Mancini. "State-of-the-Art Preclinical Photoacoustic Imaging in Oncology: Recent Advances in Cancer Theranostics". Contrast Media & Molecular Imaging 2019 (30 aprile 2019): 1–24. http://dx.doi.org/10.1155/2019/5080267.
Testo completoJentzsch, Valerie, Leeza Osipenko, Jack W. Scannell e John A. Hickman. "Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors". JAMA Network Open 6, n. 7 (28 luglio 2023): e2324977. http://dx.doi.org/10.1001/jamanetworkopen.2023.24977.
Testo completoMoore, Stephen M., James D. Quirk, Andrew W. Lassiter, Richard Laforest, Gregory D. Ayers, Cristian T. Badea, Andriy Y. Fedorov et al. "Co-Clinical Imaging Metadata Information (CIMI) for Cancer Research to Promote Open Science, Standardization, and Reproducibility in Preclinical Imaging". Tomography 9, n. 3 (11 maggio 2023): 995–1009. http://dx.doi.org/10.3390/tomography9030081.
Testo completoNunamaker, Elizabeth A., e Penny S. Reynolds. "‘Invisible actors’—How poor methodology reporting compromises mouse models of oncology: A cross-sectional survey". PLOS ONE 17, n. 10 (20 ottobre 2022): e0274738. http://dx.doi.org/10.1371/journal.pone.0274738.
Testo completoVanhoefer, U., W. Achterrath, H. Wilke e S. Seeber. "Preclinical Evaluation of Irinotecan". Oncology Research and Treatment 23, n. 4 (2000): 2–7. http://dx.doi.org/10.1159/000055047.
Testo completoBrown, Timothy, Alireza Mansouri, Samer Zammar e Michael Glantz. "CLRM-11. BENCH TO BEDSIDE NEURO-ONCOLOGY: ADVOCATING FOR A CLINICALLY RELEVANT STRATEGY AS UNDERSCORED BY THE PANDEMIC". Neuro-Oncology Advances 3, Supplement_4 (21 settembre 2021): iv3. http://dx.doi.org/10.1093/noajnl/vdab112.010.
Testo completoBegley, C. Glenn. "An Unappreciated Challenge to Oncology Drug Discovery: Pitfalls in Preclinical Research". American Society of Clinical Oncology Educational Book, n. 33 (maggio 2013): 466–68. http://dx.doi.org/10.14694/edbook_am.2013.33.466.
Testo completoGhita, Mihaela, Kathryn H. Brown, Olivia J. Kelada, Edward E. Graves e Karl T. Butterworth. "Integrating Small Animal Irradiators withFunctional Imaging for Advanced Preclinical Radiotherapy Research". Cancers 11, n. 2 (1 febbraio 2019): 170. http://dx.doi.org/10.3390/cancers11020170.
Testo completoDimakakos, Evangelos P., Ioannis Vathiotis e Konstantinos Syrigos. "The Role of Tinzaparin in Oncology". Clinical and Applied Thrombosis/Hemostasis 24, n. 5 (31 ottobre 2017): 697–707. http://dx.doi.org/10.1177/1076029617729215.
Testo completo